An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

G.A.P.G. Mastrigt; S. Evers; M. Heerings; L. H. Visser; R. Ruimschotel; A. Hussaarts; L. Duyverman; J. Valkenburg-Vissers; J. Cornelissen; M. Bos; M. Droffelaar; van der A. Zande; P.J. Jongen

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

G.A.P.G. Mastrigt, S. Evers, M. Heerings, L. H. Visser, R. Ruimschotel, A. Hussaarts, L. Duyverman, J. Valkenburg-Vissers, J. Cornelissen, M. Bos, M. Droffelaar, van der A. Zande, P.J. Jongen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	American English
Pages (from-to)	967-980
Number of pages	14
Journal	Journal of Medical Economics
Publication status	Published - 14 May 2019

Cite this

Mastrigt, G. A. P. G., Evers, S., Heerings, M., Visser, L. H., Ruimschotel, R., Hussaarts, A., Duyverman, L., Valkenburg-Vissers, J., Cornelissen, J., Bos, M., Droffelaar, M., Zande, V. D. A., & Jongen, P. J. (2019). An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. Journal of Medical Economics, 967-980.

@article{a4771579f0ba4c149821730c0ba1e94a,

title = "An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability",

author = "G.A.P.G. Mastrigt and S. Evers and M. Heerings and Visser, {L. H.} and R. Ruimschotel and A. Hussaarts and L. Duyverman and J. Valkenburg-Vissers and J. Cornelissen and M. Bos and M. Droffelaar and Zande, {van der A.} and P.J. Jongen",

year = "2019",

month = may,

day = "14",

language = "American English",

pages = "967--980",

journal = "Journal of Medical Economics",

issn = "1369-6998",

publisher = "Taylor and Francis Ltd.",

}

Mastrigt, GAPG, Evers, S, Heerings, M, Visser, LH, Ruimschotel, R, Hussaarts, A, Duyverman, L, Valkenburg-Vissers, J, Cornelissen, J, Bos, M, Droffelaar, M, Zande, VDA & Jongen, PJ 2019, 'An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability', Journal of Medical Economics, pp. 967-980.

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. / Mastrigt, G.A.P.G.; Evers, S.; Heerings, M. et al.
In: Journal of Medical Economics, 14.05.2019, p. 967-980.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

AU - Mastrigt, G.A.P.G.

AU - Evers, S.

AU - Heerings, M.

AU - Visser, L. H.

AU - Ruimschotel, R.

AU - Hussaarts, A.

AU - Duyverman, L.

AU - Valkenburg-Vissers, J.

AU - Cornelissen, J.

AU - Bos, M.

AU - Droffelaar, M.

AU - Zande, van der A.

AU - Jongen, P.J.

PY - 2019/5/14

Y1 - 2019/5/14

M3 - Article

SN - 1369-6998

SP - 967

EP - 980

JO - Journal of Medical Economics

JF - Journal of Medical Economics

ER -

Mastrigt GAPG, Evers S, Heerings M, Visser LH, Ruimschotel R, Hussaarts A et al. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. Journal of Medical Economics. 2019 May 14;967-980.